Fischer Imaging of Denver has signed a preferred-provider purchasingdeal with hospital giant Columbia Healthcare. The agreement coversFischer's Mammotest Plus breast biopsy system, Mammovision digitalspot mammography device, and Digital Traumex III
Fischer Imaging of Denver has signed a preferred-provider purchasing
deal with hospital giant Columbia Healthcare. The agreement covers
Fischer's Mammotest Plus breast biopsy system, Mammovision digital
spot mammography device, and Digital Traumex III trauma radiography
system. Under the deal, Fischer has a pre-negotiated agreement
to provide the systems to Columbia's 330 hospitals and 130 ambulatory
surgery centers.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.